Infectious disease. Combating emerging viral threats (Q35569547)

8 August 2017

Infectious disease. Combating emerging viral threats (English)

1 reference

8 August 2017

1 reference

Elena Bekerman

1

1 reference

PubMed ID

25883340

8 August 2017

Shirit Einav

series ordinal

2

1 reference

PubMed ID

25883340

8 August 2017

language of work or name

English

0 references

publication date

16 April 2015

1 reference

8 August 2017

1 reference

8 August 2017

348

1 reference

8 August 2017

282-283

1 reference

8 August 2017

6232

1 reference

Nitazoxanide: a first-in-class broad-spectrum antiviral agent

8 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4419706

Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4419706

Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4419706

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4419706

Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4419706

Curing a viral infection by targeting the host: the example of cyclophilin inhibitors

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4419706

Entry inhibitors and their use in the treatment of HIV-1 infection

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4419706

Animal models, prophylaxis, and therapeutics for arenavirus infections

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4419706

Identification and targeting of an interaction between a tyrosine motif within hepatitis C virus core protein and AP2M1 essential for viral assembly

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4419706

Productive replication of Ebola virus is regulated by the c-Abl1 tyrosine kinase

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4419706

Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and HIV by decreasing cholesterol levels in infected cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4419706

Clinical uses of interferons

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4419706

Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4419706

Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4419706

26 September 2018

Identifiers

DOI

10.1126/SCIENCE.AAA3778

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

PubMed ID

25883340